{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:20:25Z","timestamp":1786123225361,"version":"build-2736575974"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Although Von Willebrand disease (vWD) is the most common heritable bleeding disorder, there are limited reports regarding the safety of neuraxial anesthesia in the obstetric population and no definitive guidelines specifying recommended pretreatment or therapies for patients with vWD. The aim of this study is to describe the anesthetic management of pregnant patients with vWD at a large tertiary-care center.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>In this retrospective analysis, the study population was identified from vWD patients evaluated by our high-risk obstetric anesthesia consultation service and by diagnosis codes from our institutional research database registry. We manually reviewed records of patients with vWD in pregnancy who delivered at our institution between January 1, 2000 and January 1, 2019 for demographic characteristics, circumstances of vWD diagnosis, history of bleeding, laboratory studies, and overall management of vWD. Anesthetic management of vWD was at the discretion of individual providers, based on multidisciplinary consensus and the specific circumstances of each patient\u2019s disease and obstetric presentation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>We identified 106 deliveries among 71 individual vWD patients. Of the unique patients, 54 had vWD type 1, 6 had vWD type 2, and 11 had vWD type unknown. Forty-three cases (40.6%) were cesarean deliveries. Neuraxial techniques were used in 94 of 106 deliveries (88.7%). Treatment with desmopressin or Von Willebrand factor\/factor VIII concentrate before neuraxial anesthesia occurred in 27 of 94 neuraxial anesthetics (28.7%). Eleven deliveries (10.4%) were complicated by postpartum hemorrhage (PPH), defined as estimated blood loss of \u22651000 mL. There were no noted adverse anesthetic outcomes (0 of 106; 0% [95% confidence interval, 0-3.4]), including neuraxial hematoma or thromboembolic events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>In this large case series, the majority of vWD patients received neuraxial anesthesia for labor and delivery, with no noted adverse events. This suggests that neuraxial anesthesia can be safely performed with the peripartum management that we describe. Pretreatment was dictated by the type and severity of vWD. Multidisciplinary planning is important to optimize the coagulation status of patients with vWD and facilitate options for analgesia and anesthesia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1213\/ane.0000000000005502","type":"journal-article","created":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T12:07:31Z","timestamp":1619698051000},"page":"1244-1250","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":18,"title":["Anesthetic Management of Von Willebrand Disease in Pregnancy: A Retrospective Analysis of a Large Case Series"],"prefix":"10.1213","volume":"133","author":[{"given":"Sharon C.","family":"Reale","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, Perioperative and Pain Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela K.","family":"Farber","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Perioperative and Pain Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario I.","family":"Lumbreras-Marquez","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Perioperative and Pain Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean M.","family":"Connors","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean M.","family":"Carabuena","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Perioperative and Pain Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,4,29]]},"reference":[{"key":"R1-20250502","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood.V69.2.454.454","article-title":"Epidemiological investigation of the prevalence of von Willebrand\u2019s disease.","volume":"69","author":"Rodeghiero","year":"1987","journal-title":"Blood"},{"key":"R2-20250502","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0022-3476(05)80384-1","article-title":"Prevalence of von Willebrand disease in children: a multiethnic study.","volume":"123","author":"Werner","year":"1993","journal-title":"J Pediatr"},{"key":"R3-20250502","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1056\/NEJMra1601561","article-title":"Von Willebrand\u2019s disease.","volume":"375","author":"Leebeek","year":"2016","journal-title":"N Engl J Med"},{"key":"R4-20250502","first-page":"172","article-title":"Regional anesthesia in the anticoagulated patient: defining the risks (the second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation).","volume":"28","author":"Horlocker","year":"2003","journal-title":"Reg Anesth Pain Med"},{"key":"R5-20250502","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2516.2006.01314.x","article-title":"The obstetric and gynaecological management of women with inherited bleeding disorders\u2013review with guidelines produced by a taskforce of UK Haemophilia Centre Doctors\u2019 Organization.","volume":"12","author":"Lee","year":"2006","journal-title":"Haemophilia"},{"key":"R6-20250502","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/j.jogc.2017.11.036","article-title":"No. 163-gynaecological and obstetric management of women with inherited bleeding disorders.","volume":"40","author":"Demers","year":"2018","journal-title":"J Obstet Gynaecol Can"},{"key":"R7-20250502","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2516.2007.01643.x","article-title":"von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA).","volume":"14","author":"Nichols","year":"2008","journal-title":"Haemophilia"},{"key":"R8-20250502","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1097\/00000542-199904000-00043","article-title":"Epidural labor analgesia in a parturient with von Willebrand\u2019s disease type IIA and severe preeclampsia.","volume":"90","author":"Jones","year":"1999","journal-title":"Anesthesiology"},{"key":"R9-20250502","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ijoa.2007.02.013","article-title":"Epidural analgesia for parturients with type 1 von Willebrand disease.","volume":"16","author":"Marrache","year":"2007","journal-title":"Int J Obstet Anesth"},{"key":"R10-20250502","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1365-2044.1990.tb14336.x","article-title":"Epidural anaesthesia and von Willebrand\u2019s disease.","volume":"45","author":"Milaskiewicz","year":"1990","journal-title":"Anaesthesia"},{"key":"R11-20250502","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1365-2516.2007.01547.x","article-title":"Experience with epidural anaesthesia in pregnant women with von Willebrand disease.","volume":"13","author":"Varughese","year":"2007","journal-title":"Haemophilia"},{"key":"R12-20250502","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jclinane.2006.08.013","article-title":"Neuraxial anesthesia for cesarean delivery in a parturient with type 1 von Willebrand disease and scoliosis.","volume":"19","author":"Butwick","year":"2007","journal-title":"J Clin Anesth"},{"key":"R13-20250502","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1213\/ane.0b013e3181ac13d1","article-title":"Neuraxial techniques in obstetric and non-obstetric patients with common bleeding diatheses.","volume":"109","author":"Choi","year":"2009","journal-title":"Anesth Analg"},{"key":"R14-20250502","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1160\/TH12-04-0244","article-title":"Determinants of bleeding phenotype in adult patients with moderate or severe von Willebrand disease.","volume":"108","author":"de Wee","year":"2012","journal-title":"Thromb Haemost"},{"key":"R15-20250502","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1160\/TH11-03-0180","article-title":"Gynaecological and obstetric bleeding in moderate and severe von Willebrand disease.","volume":"106","author":"De Wee","year":"2011","journal-title":"Thromb Haemost"},{"key":"R16-20250502","doi-asserted-by":"crossref","first-page":"e0164683","DOI":"10.1371\/journal.pone.0164683","article-title":"Postpartum hemorrhage in women with Von Willebrand disease: a retrospective observational study.","volume":"11","author":"Govorov","year":"2016","journal-title":"PLoS One"},{"key":"R17-20250502","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1538-7836.2006.01847.x","article-title":"A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD).","volume":"4","author":"Tosetto","year":"2006","journal-title":"J Thromb Haemost"},{"key":"R18-20250502","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1213\/ANE.0000000000004424","article-title":"Trends in postpartum hemorrhage in the United States from 2010 to 2014.","volume":"130","author":"Reale","year":"2020","journal-title":"Anesth Analg"},{"key":"R19-20250502","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1213\/ANE.0000000000004560","article-title":"Introduction of a novel system for quantitating blood loss after vaginal delivery: a retrospective interrupted time series analysis with concurrent control group.","volume":"130","author":"Lumbreras-Marquez","year":"2020","journal-title":"Anesth Analg"},{"key":"R20-20250502","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJMra040403","article-title":"Treatment of von Willebrand\u2019s disease.","volume":"351","author":"Mannucci","year":"2004","journal-title":"N Engl J Med"},{"key":"R21-20250502","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0140-6736(17)30638-4","article-title":"Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial.","volume":"389","year":"2017","journal-title":"Lancet"},{"key":"R22-20250502","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/ejh.13250","article-title":"Pregnancy and delivery in women with von Willebrand disease.","volume":"103","author":"Castaman","year":"2019","journal-title":"Eur J Haematol"},{"key":"R23-20250502","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/bloodadvances.2020003265","article-title":"ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease.","volume":"51","author":"James","year":"2021","journal-title":"Blood Adv"},{"key":"R24-20250502","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1097\/00000542-200412000-00029","article-title":"Severe thrombocytopenia, type 2B von Willebrand disease and pregnancy.","volume":"101","author":"Hepner","year":"2004","journal-title":"Anesthesiology"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000005502","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:26:07Z","timestamp":1786112767000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000005502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,29]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000005502","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4,29]]}}}